Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Primary Breast Cancer × Carboplatin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 659 Lung Neoplasms 288 Ovarian Neoplasms 279 Breast Neoplasms 234 Fallopian Tube Neoplasms 140 Small Cell Lung Carcinoma 121 Triple Negative Breast Neoplasms 119 Neoplasms 116 Squamous Cell Carcinoma of Head and Neck 106 Carcinoma, Ovarian Epithelial 102 Neoplasm Metastasis 72 Head and Neck Neoplasms 67 Endometrial Neoplasms 63 Esophageal Neoplasms 59 Adenocarcinoma of Lung 58 Uterine Cervical Neoplasms 57 Brain Neoplasms 46 Central Nervous System Neoplasms 45 Recurrence 43 Prostatic Neoplasms 41 Lymphoma, Large B-Cell, Diffuse 40 Carcinoma 40 Neuroblastoma 39 Parkinson Disease 4, Autosomal Dominant Lewy Body 38 Urinary Bladder Neoplasms 37 Esophageal Squamous Cell Carcinoma 36 Lymphoma 33 Carcinoma, Squamous Cell 31 Stomach Neoplasms 29 Melanoma 29

Interventions

Docetaxel 4 Epirubicin 3 Cyclophosphamide 3 Vinorelbine 1 Tamoxifen 1 Paclitaxel 1 Iodine-123 1 Fluorouracil 1 Doxorubicin 1 Carboplatin 1 CP protocol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00527449 2010-01-15

ETCat01

Klinikum Weissenfels

Phase 2 Completed

Primary Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡